TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)

類似資料

• TUSC2 immunogene therapy synergizes with anti–PD-1 through enhanced proliferation and infiltration of natural killer cells in syngeneic Kras-mutant mouse lung cancer models
  著者:: Meraz, Ismail M, 等
  出版事項: (2018)
• TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin
  著者:: Xiaobo, Cao, 等
  出版事項: (2016)
• The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner.
  著者:: Jieru Meng, 等
  出版事項: (2013-01-01)
• The Tumor Suppressor Gene TUSC2 (FUS1) Sensitizes NSCLC to the AKT Inhibitor MK2206 in LKB1-dependent Manner
  著者:: Meng, Jieru, 等
  出版事項: (2013)
• Downregulation of the long non-coding RNA TUSC7 promotes NSCLC cell proliferation and correlates with poor prognosis
  著者:: Wang, Zhongwei, 等
  出版事項: (2016)